<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Ip-Portfolio-Analytics on Bioecon</title><link>https://en.bioecon.ru/technologies/ip-portfolio-analytics/</link><description>Recent content in Ip-Portfolio-Analytics on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Tue, 18 Aug 2026 22:19:08 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/ip-portfolio-analytics/index.xml" rel="self" type="application/rss+xml"/><item><title>Biotech IP valuation</title><link>https://en.bioecon.ru/technology/biotech-ip-valuation/</link><pubDate>Sun, 16 Aug 2026 13:16:47 +0000</pubDate><guid>https://en.bioecon.ru/technology/biotech-ip-valuation/</guid><description>Consultancies and data platforms that value biotechnology and pharmaceutical patent portfolios for licensing negotiations, M&amp;amp;A, litigation and capital raises — translating a patent estate covering therapeutics, diagnostics or platform technologies into a defensible monetary figure.</description></item></channel></rss>